IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Phio Pharmaceuticals Corp (PHIO)

CUSIP: 71880W501 | NYSE | Healthcare · Biotechnology | Micro Cap | 41 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Geode Capital Management, LLC105,686
0.0% of portfolio›$108.9K
StoneX Group Inc.11,144
0.0% of portfolio›$11.5K
Spire Wealth Management2,000
0.0% of portfolio›$2.1K
SBI Securities Co., Ltd.1,247
0.0% of portfolio›$1.3K
Assetmark, Inc110
0.0% of portfolio›$113
Activest Wealth Management9
0.0% of portfolio›$9
Caitong International Asset Management Co., Ltd3
0.0% of portfolio›$3
Barclays PLC2
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Geode Capital Management, LLC
105,686$108.9K0.0%IndexVery LowBoston, MA2026-11-06
StoneX Group Inc.
11,144$11.5K0.0%ETFMediumNew York, NY2026-11-03
Spire Wealth Management
2,000$2.1K0.0%GrowthMediumMclean, VA2026-10-30
SBI Securities Co., Ltd.
1,247$1.3K0.0%GrowthLowTokyo, Mexico2026-10-22
Assetmark, Inc
110$1130.0%ETFLowConcord, CA2026-10-21
Activest Wealth Management
9$90.0%ETFLowAventura, FL2026-10-15
Caitong International Asset Management Co., Ltd
3$30.0%GrowthVery HighHong Kong, South Korea2026-10-29
Barclays PLC
2$20.0%GrowthMediumLondon, United Kingdom2026-11-06